National Drug Strategy
National Drug Strategy

National Tobacco Strategy 2012-2018

Print page  Decrease text size  Increase text size

The National Tobacco Strategy (NTS) 2012-2018 has been developed by the Intergovernmental Committee on Drugs Standing Committee on Tobacco as a sub-strategy under the National Drug Strategy 2010-2015.

National Tobacco Strategy 2012-2018 (PDF 491 KB)
National Tobacco Strategy 2012-2018 (HTML)

The NTS 2012-2018 takes into account the public consultation on the draft for consultation of the NTS 2012-2018, the review of the National Tobacco Strategy 2004-2009, key policy contexts for tobacco control, such as the COAG National Healthcare Agreement, the COAG National Partnership Agreement on Preventive Health, the Australian Government's response to the National Preventative Health Taskforce report, state and territory tobacco strategies and policy frameworks, and recent Australian Government tobacco reform initiatives.

Nine priority areas for action underpin the goal of the NTS 2012-2018 “to improve the health of all Australians by reducing the prevalence of smoking and its associated health, social and economic costs, and the inequalities it causes”.

The NTS 2012-2018 prioritises action to protect public health policies from tobacco industry interference, eliminate the remaining advertising, promotion and sponsorship of tobacco products, and reduce the affordability of tobacco products. Other priorities focus on increasing smoke free areas, strengthening mass media and public education campaigns, improving access to evidence based cessation services, and considering further regulation of tobacco product contents, disclosure and supply.

The NTS 2012-2018 recognises the social and health inequalities associated with tobacco use, and emphasises the importance of working in partnership to reduce smoking rates among Aboriginal and Torres Strait Islander people, and other populations with a high prevalence of smoking.

At the 9 November 2012 meeting of the Standing Council on Health, the Commonwealth, state and territory Health Ministers endorsed the NTS 2012-2018 and agreed to its public release on the National Drug Strategy website.

Information about the development of the NTS 2012-2018

Mid-Point Review of the National Tobacco Strategy 2012-2018

Part Seven of the National Tobacco Strategy 2012-2018 (NTS 2012-2018) notes that in order to assess whether Australia is on track to meet the COAG performance benchmark for tobacco, a mid-point review of progress would be undertaken.

The mid-point review of the NTS 2012-2018 included two components: a data analysis and a policy analysis. Findings from the mid-point review of the NTS will assist the Commonwealth, states and territories and relevant NGOs in developing and implementing priorities in tobacco control for the remainder of the NTS 2012-2018. The findings will also provide a useful resource in the development of a new NTS beyond 2018.

The data analysis informing the mid-point review of the NTS 2012-2018 was undertaken by the Australian Institute of Health and Welfare. The key results from this work were published separately in 2016 via the report, Tobacco Indicators: measuring mid-point progress: reporting under the National Tobacco Strategy 2012-2018. Findings from this work were incorporated into the policy analysis of the midpoint review of the NTS 2012-2018.

The policy analysis was undertaken by Health Policy Analysis Pty Ltd (HPA) who conducted a targeted consultation process with officers representing the Commonwealth and state and territory tobacco control policy areas, selected non-government organisations and several key tobacco control experts.

Policy analysis – Mid-Point Review of the National Tobacco Strategy 2012-2018 (PDF 2119 KB)
Policy analysis – Mid-Point Review of the National Tobacco Strategy 2012-2018 (Word 4320 KB)

Page currency, Latest update: 18 May, 2017